BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 16537916)

  • 1. Identification and characterization of the CDK12/cyclin L1 complex involved in alternative splicing regulation.
    Chen HH; Wang YC; Fann MJ
    Mol Cell Biol; 2006 Apr; 26(7):2736-45. PubMed ID: 16537916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDK13/CDC2L5 interacts with L-type cyclins and regulates alternative splicing.
    Chen HH; Wong YH; Geneviere AM; Fann MJ
    Biochem Biophys Res Commun; 2007 Mar; 354(3):735-40. PubMed ID: 17261272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of cyclin-dependent kinase 12/CrkRS with cyclin K1 is required for the phosphorylation of the C-terminal domain of RNA polymerase II.
    Cheng SW; Kuzyk MA; Moradian A; Ichu TA; Chang VC; Tien JF; Vollett SE; Griffith M; Marra MA; Morin GB
    Mol Cell Biol; 2012 Nov; 32(22):4691-704. PubMed ID: 22988298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The regulation of glial-specific splicing of Neurexin IV requires HOW and Cdk12 activity.
    Rodrigues F; Thuma L; Klämbt C
    Development; 2012 May; 139(10):1765-76. PubMed ID: 22461565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.
    Pilch B; Allemand E; Facompré M; Bailly C; Riou JF; Soret J; Tazi J
    Cancer Res; 2001 Sep; 61(18):6876-84. PubMed ID: 11559564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CIR, a corepressor of CBF1, binds to PAP-1 and effects alternative splicing.
    Maita H; Kitaura H; Ariga H; Iguchi-Ariga SM
    Exp Cell Res; 2005 Feb; 303(2):375-87. PubMed ID: 15652350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3-kinase and Wnt pathways.
    Gonçalves V; Matos P; Jordan P
    Hum Mol Genet; 2009 Oct; 18(19):3696-707. PubMed ID: 19602482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity.
    Fotedar R; Fitzgerald P; Rousselle T; Cannella D; Dorée M; Messier H; Fotedar A
    Oncogene; 1996 May; 12(10):2155-64. PubMed ID: 8668341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of splicing factor SRp20 mRNA in bipolar disorder patients.
    Watanuki T; Funato H; Uchida S; Matsubara T; Kobayashi A; Wakabayashi Y; Otsuki K; Nishida A; Watanabe Y
    J Affect Disord; 2008 Sep; 110(1-2):62-9. PubMed ID: 18281098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of cyclin L1 and L2 interactions with CDK11 and splicing factors: influence of cyclin L isoforms on splice site selection.
    Loyer P; Trembley JH; Grenet JA; Busson A; Corlu A; Zhao W; Kocak M; Kidd VJ; Lahti JM
    J Biol Chem; 2008 Mar; 283(12):7721-32. PubMed ID: 18216018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation.
    Jumaa H; Nielsen PJ
    EMBO J; 1997 Aug; 16(16):5077-85. PubMed ID: 9305649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A.
    Gallego ME; Gattoni R; Stévenin J; Marie J; Expert-Bezançon A
    EMBO J; 1997 Apr; 16(7):1772-84. PubMed ID: 9130721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CDK/cyclin complexes in transcription and RNA splicing.
    Loyer P; Trembley JH; Katona R; Kidd VJ; Lahti JM
    Cell Signal; 2005 Sep; 17(9):1033-51. PubMed ID: 15935619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific commitment of different pre-mRNAs to splicing by single SR proteins.
    Fu XD
    Nature; 1993 Sep; 365(6441):82-5. PubMed ID: 8361546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and characterization of p10, an alternatively spliced form of p15 cyclin-dependent kinase inhibitor.
    Tsubari M; Tiihonen E; Laiho M
    Cancer Res; 1997 Jul; 57(14):2966-73. PubMed ID: 9230210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual effect of the SR proteins ASF/SF2, SC35 and 9G8 on HIV-1 RNA splicing and virion production.
    Jacquenet S; Decimo D; Muriaux D; Darlix JL
    Retrovirology; 2005 May; 2():33. PubMed ID: 15907217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ASF/SF2-like maize pre-mRNA splicing factors affect splice site utilization and their transcripts are alternatively spliced.
    Gao H; Gordon-Kamm WJ; Lyznik LA
    Gene; 2004 Sep; 339():25-37. PubMed ID: 15363843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus regulation of SR proteins.
    McFarlane M; Graham SV
    Biochem Soc Trans; 2010 Aug; 38(4):1116-21. PubMed ID: 20659014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus E1A-associated p33 kinase.
    Tsai LH; Harlow E; Meyerson M
    Nature; 1991 Sep; 353(6340):174-7. PubMed ID: 1653904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning of a gene (SR-A1), encoding for a new member of the human Ser/Arg-rich family of pre-mRNA splicing factors: overexpression in aggressive ovarian cancer.
    Scorilas A; Kyriakopoulou L; Katsaros D; Diamandis EP
    Br J Cancer; 2001 Jul; 85(2):190-8. PubMed ID: 11461075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.